Tech Company Financing Transactions
IFM Therapeutics Funding Round
IFM Therapeutics, based in Boston, secured $55.5 million from Omega Funds, Abingworth and Atlas Venture.
Transaction Overview
Company Name
Announced On
12/3/2019
Transaction Type
Venture Equity
Amount
$55,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to launch its third subsidiary, IFM Quattro, as well as a new incubator, IFM Discovery.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
855 Boylston St. 11th Floor
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Website
Email Address
Overview
At IFM Therapeutics, we are driven to invent transformative therapies to improve the lives of patients with serious, life threatening diseases. We are passionate about building a company that embraces creativity, integrity, and excellence.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Gary Glick
Chief Executive Officer
Martin Seidel
Vice President
Ed Olhava
VP - Bus. Development
Dennis Dean
VP - Operations
Lina Gugucheva
Browse more venture capital transactions:
Prev: 12/2/2019: Ockam.io venture capital transaction
Next: 12/4/2019: Accel Robotics venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs